Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results90% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (5)
P 4 (2)

Trial Status

Completed9
Recruiting4
Unknown3
Enrolling By Invitation2
Not Yet Recruiting2
Terminated1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT06728735RecruitingPrimary

Role of Next Generation Sequencing in the Etiological Diagnosis of Permanent Congenital Hypothyroidism With in Situ Thyroid

NCT06724224RecruitingPrimary

Comparison of Levothyroxine Formulations in the Treatment of Congenital Hypothyroidism

NCT07425028Not Yet RecruitingPrimary

Evaluation of an Intensified Systematic Screening for Congenital Hypothyroidism in Premature Newborns

NCT07280104RecruitingPrimary

Infants With Primary Congenital Hypothyroidism and Development

NCT05228184Phase 4TerminatedPrimary

Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)

NCT01916018Not ApplicableCompletedPrimary

Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis.

NCT06864351Not ApplicableRecruiting

Prospective Evaluation of OptiThyDose

NCT07126353Not Yet RecruitingPrimary

Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism

NCT05687474Completed

Baby Detect : Genomic Newborn Screening

NCT03655223Enrolling By Invitation

Early Check: Expanded Screening in Newborns

NCT06864039Not ApplicableEnrolling By InvitationPrimary

Quality of Life and Long-term Outcome of Adequately Treated Congenital Hypothyroidism

NCT05371262Phase 4CompletedPrimary

Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism

NCT04734457UnknownPrimary

Final Height in Patients With CH Diagnosed by the Screening

NCT04712760UnknownPrimary

Congenital Hypothyroidism in Children With Eutopic Gland or Thyroid Hemiagenesis: Predictive Factors for Transient vs Permanent Hypothyroidism.

NCT00403390Not ApplicableCompletedPrimary

Generic vs. Name-Brand Levothyroxine

NCT02307175Completed

A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication

NCT02374593Not ApplicableCompletedPrimary

Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism

NCT01223638WithdrawnPrimary

The Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism

NCT01488721Completed

Clinical Evaluation of NeoPlex4 Assay and NeoPlex System

NCT00505479UnknownPrimary

Iodine Status in Pregnant Women and Their Newborns: is Congenital Hypothyroidism Related to Iodine Deficiency in Pregnancy?

Scroll to load more

Research Network

Activity Timeline